Ramtin Agah - 21 Jan 2026 Form 4 Insider Report for RenovoRx, Inc. (RNXT)

Role
Chief Medical Officer, Director
Signature
/s/ Ramtin Agah
Issuer symbol
RNXT
Transactions as of
21 Jan 2026
Net transactions value
+$9,975
Form type
4
Filing time
22 Jan 2026, 07:00:18 UTC
Previous filing
05 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Agah Ramtin Chief Medical Officer, Director C/O RENOVORX, INC., 2570 W EL CAMINO REAL, SUITE 320, MOUNTAIN VIEW /s/ Ramtin Agah 22 Jan 2026 0001862617

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RNXT Common Stock Purchase $9,975 +10,000 +1.3% $0.9975 798,460 21 Jan 2026 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects open market purchases of the Issuer's securities.
F2 Reflects a weighted average price. The securities were purchased in multiple transactions at per share prices ranging from $0.995 to $1.00.